Abstract
Typical efficacy endpoints have their associated statistical techniques. For example, values of continuous measurements (e.g., blood pressures) require the following statistical techniques:
-
(a)
if measurements are normally distributed: t-tests and associated confidence intervals to compare two mean values; analysis of variance (ANOVA) to compare three or more
-
(b)
if measurements have a non-normal distribution: Wilcoxon rank tests with confidence intervals for medians.
Comparing proportions of responders or proportions of survivors or patients with no events involves binomial rather than normal distributions and requires a completely different approach. It requires a chi-square test, or a more complex technique otherwise closely related to the simple chi-square test, e.g., Mantel Haenszl summary chi-square test, logrank test, Cox proportional hazard test etc. Although in clinical trials, particularly phase III–IV trials, proportions of responders and proportion of survivors is increasingly an efficacy endpoint, in many other trials proportions are used mainly for the purpose of assessing safety endpoints, while continuous measurements are used for assessing the main endpoints, mostly efficacy endpoints. We will, therefore, focus on statistically testing continuous measurements in this chapter and will deal with different aspects of statistically testing proportions in the next chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Matthews DE, Farewell VT. Using and understanding medical statistics. Karger, Melbourne, Australia, 1996.
Cohen A, Posner J. Clinical Drug Research. Kluwer Academic Publishers, Dordrecht, Netherlands, 1995.
Bailar JC, Mosteller F. Medical Uses of Statistics. N Engl J Med Books, Waltham, MA, 1986.
Swinscow TD. Statistics at square one. BMJ Publishing Group, London, UK, 1996.
Glantz SA. Primer of Biostatistics. McGraw-Hill, Singapore, 1992.
Motulsky H. Intuitive Statistics. Oxford University Press. New York, 1995.
Kuhlmann J, Mrozikiewicz A. What should a clinical pharmacologist know to start a clinical trial? Zuckschwerdt Verlag, Munich, 1998.
De Vocht A. SPSS basic guide book. Bijleveld Press, Amsterdam, 1998.
Hays WL. Statistics. Holt, Rine and Winston, Toronto, Ontario, 1988.
Kirkwood BR. Medical statistics. Blackwell Scientific Publications, Boston, MA, 1990.
Petrie A, Sabin C. Medical Statistics at a Glance. Blackwell Science, London, UK, 2000.
Riffenburgh RH. Statistics in Medicine. Academic Press. New York, USA, 1999.
Utts JM. Seeing through Statistics. Brooks Cole Company, Pacific Grove, CA, 1999.
Glaser AN. High Yield Statistics. Lippincott, Williams & Wilkins Baltimore, Maryland, 2001.
Petrie A, Sabin C. Medical Statistics at a Glance. Blackwell Science. Malden, MA, 2000.
Lu Y, Fang JQ. Advanced Medical Statistics. World Scientific, River Edge, NJ, 2003.
Riegelman RK. Studying a study and testing a test. Lippincott Williams & Wilkins, 5th Edition, Philadelphia, 2005.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Cleophas, T.J., Zwinderman, A.H., Cleophas, T.F. (2006). The Analysis of Efficacy Data of Drug Trials. In: Statistics Applied to Clinical Trials. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-4650-6_2
Download citation
DOI: https://doi.org/10.1007/978-1-4020-4650-6_2
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-4229-4
Online ISBN: 978-1-4020-4650-6
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)